MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0012523
Kesar Pharma Limited - pharma in Gandhinagar, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹20.63 Cr
▼ 26% YoY
Net profit · FY 2025
₹21.49 Lakh
Net margin 1%
EBITDA · FY 2025
₹1.82 Cr
EBITDA margin 8.8%
Authorised capital
₹6.9 Cr
Registered with MCA
Paid-up capital
₹4.32 Cr
Issued & subscribed
Open charges
₹10.58 Cr
Satisfied ₹14.65 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
47
Provident fund records
About Kesar Pharma Limited
Data last updated:
Kesar Pharma Limited is a public limited company based in Gandhinagar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2011PLC067520. Its GSTIN is 24AAECK5207A2Z6 (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6.9 Cr and a paid-up capital of ₹4.32 Cr. It was formerly known as Kesar Swasthya Private Limited. It is led by directors including Parth Hemant Parikh and Kevin Atul Vasani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot Survey No. 50 – P2 At Village Bileshwarpura Po. Chhatral Ta. Kalol, Gandhinagar, Gujarat, India – 382729.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.63 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹21.49 Lakh (net margin 1%) and EBITDA of ₹1.82 Cr (EBITDA margin 8.8%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 9% over five years.
The company has about 47 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Kesar Pharma. As per MCA filings, the company has open charges of ₹10.58 Cr and satisfied charges of ₹14.65 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 3 deals on record (1 rights issue, 1 funding round, 1 convertible or debt financing), with disclosed funding of ₹7 Cr; the latest was in August 2016. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Snehal Pharma & Surgicals Private Limited with revenue of ₹20.74 Cr. The company has 3 MSME Form 1 returns on record between 2019 and 2021, listing 164 overdue payments to 33 micro and small suppliers.
Kesar Pharma Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0012523). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kesarpharma.com.
Company details
CIN U24239GJ2011PLC067520
Registration Number 067520
Incorporation Date 18 October 2011
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0012523
CIN history
Kesar Pharma has one previous CIN (Corporate Identification Number): U24239GJ2011PTC067520. The current CIN is U24239GJ2011PLC067520, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239GJ2011PLC067520 | Current |
| U24239GJ2011PTC067520 | Previous |
Recognitions & Rankings of Kesar Pharma
Contact details
Kesar Pharma Limited's registered office is in Gandhinagar, Gujarat. Its website is kesarpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot Survey No. 50 – P2 At Village Bileshwarpura Po. Chhatral Ta. Kalol, Gandhinagar, Gujarat, India – 382729
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kesar Pharma Limited, buy the company report.
Comprehensive company report
Kesar Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Kesar Pharma operates one associated brand: Kesar Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical finished formulations including tablets and capsules are manufactured. | kesarpharma.com |
Business activity
The main business activity of Kesar Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kesar Pharma Limited, buy the company report.
Financials of Kesar Pharma Limited
FY 2025 filings availableKesar Pharma Limited reported revenue of ₹20.63 Cr (down 26% YoY) for FY 2025.
Revenue · FY 2025
₹20.63 Cr ▼ 26%
Net profit · FY 2025
₹21.49 Lakh margin 1%
EBITDA · FY 2025
₹1.82 Cr margin 8.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 26%
3 years · compounded
▼ 25%
5 years · compounded
▼ 9%
EBITDA CAGR growth
1 year
▼ 31%
3 years · compounded
▼ 24%
5 years · compounded
▼ 1%
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 26% fall in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.82 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kesar Pharma Limited, buy the company report.
Board of directors of Kesar Pharma Limited
Kesar Pharma has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parth Hemant Parikh | Director | 06 Sep 2019 | 7 Years 1 Months | Current |
| Kevin Atul Vasani Also directs: Quantum Quench Health Private Limited | Director | 15 Apr 2025 | 1 Years 6 Months | Current |
| Prakash Ambalal Patel Also directs: Dhwanit Consultancy LLP, Kesar Finechem Private Limited, Hapax Pharma Private Limited and 2 more | Director | 18 Oct 2011 | 15 Years 0 Months | Current |
| Kalpesh Navnitlal Shah Also directs: Kesar Finechem Private Limited, Hapax Pharma Private Limited | Director | 01 May 2014 | 12 Years 5 Months | Current |
| Rumit Bharatbhai Gopani | Director | 15 Apr 2025 | 1 Years 6 Months | Current |
Peer comparison
Kesar Pharma Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Snehal Pharma & Surgicals Private Limited | ₹20.74 Cr (FY 2024) | -25.0% | Mumbai, Maharashtra, India | |||
| Sheetal Chemicals Private Limited | ₹20.73 Cr (FY 2025) | 119.0% | Hyderabad, Telangana, India | |||
| Instant Remedies Private Limited | ₹20.64 Cr (FY 2025) | -7.0% | Chandigarh, India | |||
| Kesar Pharma Limitedthis company | ₹20.63 Cr (FY 2025) | ₹21.49 Lakh | 1% | -26.0% | 47 | Gandhinagar, Gujarat, India |
| Dewcare Concept Private Limited | ₹20.61 Cr (FY 2025) | 2.0% | Ahmedabad, Gujarat, India | |||
| Bda Health Care Private Limited | ₹20.61 Cr (FY 2025) | 1.0% | Parshivani, Maharashtra, India | |||
| Medizest Pharmaceuticals Private Limited | ₹20.59 Cr (FY 2024) | 54.0% | Verna, Goa, India | |||
| Morvin India Health Care Private Limited | ₹20.53 Cr (FY 2025) | 14.0% | Sanand, Gujarat, India |
To see the full peer comparison of Kesar Pharma Limited, buy the company report.
Auditor
Kesar Pharma Limited is audited by PIYUSH J. SHAH & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PIYUSH J. SHAH & CO | FY 2024 | 121172W |
Shareholding
The shareholding of Kesar Pharma Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kesar Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹10.58 Cr
Satisfied charges
₹14.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 2025 | 101083682 | Hdb Financial Services Limited | ₹6.06 Cr | Open | |
| 05 Feb 2024 | 100882536 | Sidbi | ₹1.4 Cr | Open | |
| 28 Mar 2023 | 100692287 | Sidbi | ₹62.76 Lakh | Open | |
| 06 Feb 2021 | 100412354 | Others | ₹55 Lakh | Open | |
| 07 Sep 2020 | 100366621 | Others | ₹1.44 Cr | Open |
To see the full charge records of Kesar Pharma Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Kesar Pharma Limited has 3 deals on record (1 rights issue, 1 funding round, 1 convertible or debt financing), with disclosed funding of ₹7 Cr; the latest was in August 2016.
Total deals
3
Rights issue
1
Funding round
1
Convertible or debt financing
1
Disclosed funding
₹7 Cr
Deals on record (2 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Rights issue | ₹1.41 Cr | Investors: 4 individuals |
| Mar 2012 | Funding round | ₹2 Cr | Investors: 4 individuals |
To see the full deal history of Kesar Pharma Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Kesar Pharma Limited has 1 court case on record: 1 filed by Kesar Pharma. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of Kesar Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Kesar Pharma Limited has 3 MSME Form 1 returns on record between 2019 and 2021, listing 164 overdue payments to 33 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 33)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Allpharma Care Private Limited | |||
| Asian Flavours & Fragrances | |||
| an individual supplier | |||
| S K Packaging | |||
| Rakesh Chemicals (Chhatral) |
To see the full MSME payment records of Kesar Pharma Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Kesar Pharma has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Kesar Finechem Private Limited | U24230GJ2021PTC127102 |
To see the full group structure of Kesar Pharma Limited, buy the company report.
Employees & EPFO
Kesar Pharma Limited has a workforce of 47 employees on its EPFO records as of Feb 24, 2025, across 1 active EPFO establishment.
Employee count
47
Active EPFO establishments
1
Employee growth
-16.07%
GST
Kesar Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECK5207A2Z6 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kesar Pharma Limited, buy the company report.
Recent activity
Kesar Pharma Limited has 15 board changes on record since 2011: 5 appointments and 10 cessations. The latest: Kevin Atul Vasani ceased to be Additional Director on 07 May 2025.
AGM
Kesar Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Kevin Atul Vasani ceased to be Additional Director.
Ceased
Rumit Bharatbhai Gopani ceased to be Additional Director.
Appointed
Kevin Atul Vasani was appointed as Director.
Appointed
Rumit Bharatbhai Gopani was appointed as Director.
Filing
Kesar Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 20 Dec 2019 via Charge ID 100310109 with Others was fully satisfied on 19 Feb 2025.
Charges
A charge with Hdb Financial Services Limited amounted to Rs. 6.06 Cr with Charge ID 101083682 was registered on 31 Jan 2025.
Charges
A charge with Sidbi amounted to Rs. 1.40 Cr with Charge ID 100882536 was registered on 05 Feb 2024.
Charges
A charge with Sidbi amounted to Rs. 0.63 Cr with Charge ID 100692287 was registered on 28 Mar 2023.
Charges
A charge registered on 23 Jun 2021 via Charge ID 100451839 with Sidbi was fully satisfied on 11 Nov 2022.
Charges
A charge with Others of Rs. 1.44 Cr registered on 07 Sep 2020 with Charge ID 100366621 was modified on 24 Jan 2022.
26 earlier events are in the company report.
Frequently asked questions
Kesar Pharma is an active public limited company based in Gandhinagar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 October 2011 (15+ years old) and is registered under CIN U24239GJ2011PLC067520.
Kesar Pharma has 5 current directors:
- Parth Hemant Parikh - Director
- Kevin Atul Vasani - Director
- Prakash Ambalal Patel - Director
- Kalpesh Navnitlal Shah - Director
- Rumit Bharatbhai Gopani - Director
The latest financial statements of Kesar Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kesar Pharma is 24AAECK5207A2Z6, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Kesar Pharma is U24239GJ2011PLC067520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kesar Pharma has 1 court case on record: 1 filed by the company.
Kesar Pharma was incorporated on 18 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Kesar Pharma has 3 deals on record (1 rights issue, 1 funding round, 1 convertible or debt financing), with disclosed funding of ₹7 Cr; the latest was in August 2016.
The peers of Kesar Pharma by revenue are Snehal Pharma & Surgicals Private Limited, Sheetal Chemicals Private Limited, Instant Remedies Private Limited, Dewcare Concept Private Limited, Bda Health Care Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kevin Atul Vasani ceased to be Additional Director on 07 May 2025. Rumit Bharatbhai Gopani ceased to be Additional Director on 07 May 2025. Kevin Atul Vasani was appointed as Director on 15 Apr 2025. Kesar Pharma has 15 board changes on record in total.
Yes, Kesar Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0012523).
Kesar Pharma has 3 MSME Form 1 returns on record between 2019 and 2021, listing 164 overdue payments to 33 micro and small suppliers. The latest return was filed on 26 Apr 2021.